Filling Date Form TypeDescription  
  
Data pager
 Page 1 of 9, items 1 to 13 of 110.
2019-05-1010-QQuarterly report [Sections 13 or 15(d)]Acc-no: 0001388410-19-000058 (34 Act)  Size: 5 MB
2019-05-078-KCurrent report, items 1.01, 3.02, and 9.01 Acc-no: 0001388410-19-000047 (34 Act)  Size: 2 MB
2019-04-198-KCurrent report, items 1.01, 2.03, 3.02, and 9.01 Acc-no: 0001388410-19-000044 (34 Act)  Size: 1 MB
2019-04-098-KCurrent report, items 1.01, 2.03, 3.02, and 9.01 Acc-no: 0001388410-19-000042 (34 Act)  Size: 13 MB
2019-04-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]Acc-no: 0001388410-19-000040 (34 Act)  Size: 10 MB
2019-04-018-KCurrent report, items 7.01 and 9.01 Acc-no: 0001388410-19-000034 (34 Act)  Size: 8 MB
2019-03-228-KCurrent report, items 1.01, 2.03, 3.02, and 9.01 Acc-no: 0001388410-19-000029 (34 Act)  Size: 515 KB
2019-03-198-KCurrent report, items 3.02, 3.03, 5.02, and 9.01 Acc-no: 0001388410-19-000026 (34 Act)  Size: 8 MB
2019-03-158-KCurrent report, items 1.01, 2.03, 3.02, and 9.01 Acc-no: 0001388410-19-000022 (34 Act)  Size: 1 MB
2019-03-1110-Q/A[Amend] Quarterly report [Sections 13 or 15(d)]Acc-no: 0001388410-19-000020 (34 Act)  Size: 6 MB
2019-02-058-KCurrent report, item 3.02 Acc-no: 0001388410-19-000017 (34 Act)  Size: 29 KB
2019-01-308-KCurrent report, item 5.03 Acc-no: 0001388410-19-000015 (34 Act)  Size: 30 KB
2019-01-285Annual statement of changes in beneficial ownership of securitiesAcc-no: 0001388410-19-000013 Size: 7 KB

Parallax Health Sciences Reports First Quarter 2019 Operating and Financial Results
5/13/2019 10:00:00 AM

Revenue increased959% and a 56% reduction in expenses over prior-year period Recordscash sale for the first licensing of its technology SANTA MONICA, CA / ACCESSWIRE / May13, 2019 / Parallax Health Sciences, ...


Parallax Health Sciences to Participate at the Planet MicroCap Showcase 2019
4/25/2019 6:25:00 PM

SANTA MONICA, CA / ACCESSWIRE / April 25, 2019 / Parallax Health Sciences, Inc. (OTCQB: PRLX) (''Parallax'' or the ''Company''), an outcome-driven connected healthcare company, announces that management ...


Parallax Health Sciences Reports 2018 Operating and Financial Results Records Net Income of $16.3 Million
4/1/2019 10:00:00 AM

Initiates $6 Million Equity Financing Company Now Positioned for Growth through Execution on Multi-faceted Strategy SANTA MONICA, CALIF / ACCESSWIRE / April 1, 2019 / Parallax Health Sciences, Inc. (OTCQB: ...


Parallax to Present at The MicroCap Conference on April 2
3/28/2019 10:00:00 AM

SANTA MONICA, CA / ACCESSWIRE / March 28, 2019 / Parallax Health Sciences, Inc. (OTCQB: PRLX) (''Parallax'' or the ''Company''), an outcome-driven connected healthcare company, announces that management ...


Parallax Health Sciences Appoints Pete Scobell to Board of Advisors
3/5/2019 11:00:00 AM

SANTA MONICA, CA / ACCESSWIRE / March 5, 2019 / Parallax HealthSciences, Inc. (PRLX) (''Parallax'' or the ''Company''), an outcome-driven connected healthcare company, announces that Pete Scobell has joined the Company's Advisory Board. Mr. Scobell brings Parallax strong leadership skills and telehealth marketing experience. Mr. Scobell is the founder and Chief Executive Officer of Valor Industries, a disruptive sports equipment manufacturer that provides protective equipment and technology for athletes worldwide.


Parallax Care Outcomes Platform Subject of MHCA 2019 Keynote Address
2/4/2019 8:25:00 PM

SANTA MONICA, CA / ACCESSWIRE / February 4, 2019 / Parallax Health Sciences, Inc. (PRLX) ("Parallax" or the "Company"), an outcomes-driven connected healthcare company, announces that Parallax's CTO, Nathaniel Bradley will deliver the keynote address at the Mental Health Corporations of America ("MHCA") Annual Conference on Wednesday, February 20, 2019 at the Opal Sands resort Clearwater Beach, Florida. "Parallax Care, our industry first outcomes optimizing platform, features a patented and reliable evidence-based outcomes optimization technology that has been integrated with Parallax's Intrinsic Code to provide interventional medical and pharmaceutical adherence management systems," stated Nathaniel Bradley, Parallax's Chief Technology Officer.


Parallax Integrates its Connected Health Platform into EZ Waiting Room App, Gains Access to 330,000 Physicians
1/28/2019 11:00:00 AM

SANTAMONICA, CA / ACCESSWIRE / January 28, 2019 / Parallax Health Sciences, Inc. (PRLX) ("Parallax" or the "Company"), an outcomes-driven connected healthcare company, announces an agreement whereby its wholly-owned subsidiary Parallax Communications, Inc. ("PCOM") will integrate its connected health platform into EZ Waiting Room's app. More than 330,000 doctors in the EZ Waiting Room network will be able to direct patients to monitor their treatments through the PCOM connected health platform.


Seasoned Healthcare Veteran Dr. Sylvan Waller Joins Parallax Health Sciences Advisory Board
12/18/2018 12:00:00 PM

SANTA MONICA, CA / ACCESSWIRE / December 17, 2018 / Parallax Health Sciences, Inc. (PRLX) (''Parallax'' or the ''Company''), an outcome-driven connected healthcare company, announces that Sylvan Waller, M.D., FACEP has joined the Company's Advisory Board. Dr. Waller is a board-certified emergency medicine physician with more than 18 years of medical, financial management, business operations and executive leadership experience.


Parallax Health Sciences Shares Now Trade on the OTCQB(R) Venture Market
11/21/2018 12:00:00 PM

SANTA MONICA, CA / ACCESSWIRE / November 21, 2018 / Parallax Health Sciences, Inc. (PRLX) ("Parallax" or the "Company"), an outcome-driven connected healthcare company, is pleased to report that its common shares are now trading on the OTCQB ® Venture Market. Mr. Arena continued, "The U.S. Congress is now considering the Reducing Unnecessary Senior Hospitalization (RUSH) Act, which aims to reduce rehospitalizations using telemedicine and telehealth to improve patient care and reduce costs.


Parallax Health Sciences Reports Third Quarter Financial Results
11/15/2018 12:00:00 PM

Liabilities from continuing operations reduced by $24.5 million in Q3, and $18.2 million net income year-to-date Company positioned for future success with breakeven from operations expected by 2019 year ...


Parallax Health Sciences Names Dr. David Stark President of Parallax Diagnostics
10/12/2018 12:48:00 PM

SANTA MONICA, CA / ACCESSWIRE / October 12, 2018 / Parallax Health Sciences, Inc. (OTC PINK: PRLX) (''Parallax''), a technology-driven connected healthcare company, announces the appointment of David Stark in a dual role of President of Parallax Diagnostics, Inc. A wholly owned subsidiary of Parallax Health Sciences, Parallax Diagnostics is developing an innovative, mobile point of care testing platform for use doctors offices, and remote monitoring of patients. Parallax's Mobile immunoassay analyzer and flow through Target Cartridges are currently Patented in the US, China, Hong Kong and India and deliver laboratory-quality results inside of 10 minutes and at a reduced cost of comparable laboratory tests.


Parallax Health Sciences and Pareteum Corporation Partner to Create Healthcare Industry's First Globally Connected Direct-to-Consumer Virtual Network Operator
10/2/2018 10:30:00 AM

SANTA MONICA, CA and NEW YORK, NY / ACCESSWIRE / October 2, 2018 / Parallax Health Sciences, Inc. (OTC PINK: PRLX) (''Parallax''), a technology-driven connected healthcare company, today announced that it has partnered with Pareteum Corporation (TEUM) (''Pareteum'') to extend its remote healthcare offerings portfolio. The innovative strategy, which derives from the integration of Parallax and Pareteum's mobile platform technologies, will result in the establishment of Parallax Communications (''PCOM'') as the first remote patient care mobile virtual network operator (''MVNO'').


Parallax to Present at The MicroCap Conference on October 2
9/27/2018 11:00:00 AM

SANTA MONICA, CA / ACCESSWIRE / September 27, 2018 / Parallax Health Sciences, Inc. (OTC PINK: PRLX), a technology-driven connected healthcare company, announces that management will present at The MicroCap ...


Parallax Announces Investment Community Conference Call
9/5/2018 10:00:00 AM

Company to Provide Update on its Uplisting and the Impact of Recent Patent Rights Issued to Parallax within the Connected Healthcare Industry SANTA MONICA, CA / ACCESSWIRE / September 5, 2018 / Parallax ...


Parallax Announces Rescheduling of Investment Community Conference Call
8/28/2018 10:05:00 AM

Company to Provide Progress Report in Developing Novel Healthcare Solutions for Remote Patient Monitoring and Connected Care SANTA MONICA, CA / ACCESSWIRE / August 28, 2018 / Parallax Health Sciences, ...


Parallax Announces Shareholder Call with CTO to Discuss Newly Issued Patent Covering Data Driven Outcomes and Intellectual Property Portfolio
8/23/2018 1:15:00 PM

SANTA MONICA, CA / ACCESSWIRE / August 23, 2018 / Parallax Health Sciences, Inc. (OTC PINK: PRLX), a technology-driven connected healthcare company, announced today that its Chief Technology Officer Nathaniel ...


Parallax Behavioral Health Issued Revolutionary United States Patent For Data Driven Outcomes Platform
8/20/2018 10:05:00 AM

SANTA MONICA, CA / ACCESSWIRE / August 20, 2018 / Parallax Health Sciences, Inc. (OTC PINK: PRLX), a technology-driven digital healthcare company, announces that its wholly-owned subsidiary Parallax Behavioral Health (PBH) is the recipient of United States Patent #10,061,812 entitled, "Platform for optimizing data driven outcomes" now protecting Parallax's technology platforms and proprietary and industry first solutions. Parallax Behavioral Health acquired all of the assets of ProEventa, Inc. in September of 2017, a company developed by the Grafton Integrated Health Network of Virginia, including a patent portfolio filed to protect an industry first and proven Goal Mastery Platform known as R.E.B.O.O.T. which was patent pending at time of acquisition.